Mitochondrial myopathies

14 September 2023

…THEME: Mitochondrial Myopathies​

…PRESENTER: Prof. Dr. Anders Oldfors (University of Gothenburg and Sahlgrenska University Hospital, Sweden)

…BIOSKETCH: Anders Oldfors studied medicine in Gothenburg, Sweden between 1969 and 1975. After his PhD thesis in 1980 he did a post doc with Michel Fardeau in Paris, 1981.

During specialization in surgical pathology 1982-1985 he initiated diagnostic service and research in muscle pathology in Gothenburg. The research was initially focussed on mitochondrial diseases in an interdisciplinary network of pioneers in the mitochondrial disease field. His interest in pathology of mitochondrial diseases has continued over the years and he has published more than 90 scientific articles in this field.

He started early to combine pathology and genetics in the lab to identify new muscle diseases, mainly in the field of mitochondrial diseases, congenital myopathies such as myosin myopathies and glycogen storage diseases. Another longstanding and still ongoing project concerns inflammatory myopathies especially inclusion body myositis.

His interest in muscle pathology has led to authorship of chapters in several books on muscle diseases as well as authorship of the 4th and 5th editions of the book “Muscle Pathology- a practical approach” (by Dubowitz, Sewry and Oldfors). In January 2023 he is co-author of 287 articles listed in PubMed with an h-index of 67 (Google Scholars).

After organizing the 9th World Muscle Society (WMS) international congress in Gothenburg 2004, he has been a continuous member of the Executive Board of WMS and a member of the Editorial Board of Neuromuscular Disorders, the official journal of WMS. From 2020 he is Editor-in-Chief of Neuromuscular Disorders after the retirement of Victor Dubowitz.

In his home institution, the University of Gothenburg, he was head of the Institute of Biomedicine, one of the four Institutes of the Medical Faculty in Gothenburg from 2006-2018. At present he is senior professor at the University of Gothenburg and consultant pathologist at the Sahlgrenska University Hospital.

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit